| Positive Rankings |
Estimated Revenue Growth
Cara Therapeutics Inc. rank is 14 |
Positive Stoch Cross
Cara Therapeutics Inc. rank is 91 |
Target Prices
The average analysts' target price is $30.00 for Cara Therapeutics Inc. using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Cara Therapeutics Inc. is ranked 194. |
Debt-to-Equity
Cara Therapeutics Inc. rank is 221 |
Highest Cash Growth
Cara Therapeutics Inc. rank is 341 |
Low Put/Call
Cara Therapeutics Inc. has a low Put/Call ratio of 0.37 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cara Therapeutics Inc. is ranked 1027. |
| Negative Rankings |
Price-to-Sales
Cara Therapeutics Inc. rank is 106 |
Missed Whisper
According to EarningsWhispers.com, Cara Therapeutics Inc. missed the Earnings Whisper ® number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper ® number underperform the market in the short-term. |
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator. |
Negative Net Margin
Cara Therapeutics Inc. rank is 200 |
Negative ROA
Cara Therapeutics Inc. rank is 457 |
Down EPS Surprise
Cara Therapeutics Inc. missed the consensus earnings estimate when it last reported quarterly earnings. |
Negative ROE
Cara Therapeutics Inc. rank is 492 |
Price-to-Book
Cara Therapeutics Inc. rank is 639 |
Negative Revenue Growth
Cara Therapeutics Inc. rank is 673 |
10 Day Loss
Cara Therapeutics Inc. rank is 1278 |
High vPut/Call
Cara Therapeutics Inc. has a high Put/Call ratio of 0.91 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Cara Therapeutics Inc. is ranked 1468. |
90 Day Loss
Cara Therapeutics Inc. rank is 1815 |
